Psoralen stimulates osteoblast differentiation through activation of BMP signaling

Biochemical and Biophysical Research Communications

Volumn 405, Issue 2, 2011, Pages 256-261

  Tang, De Zhi ^a,b   Yang, Feng ^a   Yang, Zhou ^a   Huang, Jian ^b   Shi, Qi ^a   Chen, Di ^b   Wang, Yong Jun ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

BMP 2; BMP 4; Osteoblast; Osteoporosis; Psoralen

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE SIALOPROTEIN; COLLAGEN TYPE 1; OSTEOCALCIN; OSX PROTEIN; PROTEIN; PSORALEN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; SKULL; UPREGULATION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FICUSIN; MICE; OSTEOBLASTS; OSTEOPOROSIS; SIGNAL TRANSDUCTION;

EID: 79651475048     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.021     Document Type: Article

References (24)

1. Christiansen C. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 1993, 94:646-650.
2. Lindsay R. Osteoporosis. A Guide to Diagnosis, Prevention, and Treatment 1992, Raven Press, New York.
3. Chrischilles E.A., Butler C.D., Davis C.S., et al. A model of lifetime osteoporosis impact. Arch. Intern. Med. 1991, 151:2026-2032.
4. US Congress OoTA, Hip Fracture Outcomes in People Age 50 and Over-Background Paper, US Government Printing Office, Washington, DC, 1994.
5. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
6. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
7. Lane N.E., Kelman A. A review of anabolic therapies for osteoporosis. Arthritis. Res. Ther. 2003, 5:214-222.
8. Wong R.W.K., Rabie A.B.M. Effect of psoralen on bone formation. J. Orthop. Res. 2010, 3:1-5.
9. Miura H., Nishida H., Linuma M. Effect of crude fraction of Psoralea corylifolia seed extract on bone calcification. Planta Med. 1996, 62:150-153.
10. Wong R.W.K., Rabie A.B.M. Effect of Buguzhi (Psoralea corylifolia fruit) extract on bone formation. Phytother. Res. 2010, 24(Suppl. 2):S233-S234.
11. Sykaras N., Opperman L.A. Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J. Oral Sci. 2003, 45:57-73.
12. Styrkarsdottir U., Cazier J.B., Kong A., et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 2003, 1:E69.
13. Ramesh Babu L., Wilson S.G., Dick I.M., et al. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 2005, 36:555-561.
14. Xiao Y., Haase H., Young W.G., Bartold P.M. Development and transplantation of a mineralized matrix formed by osteoblasts in vitro for bone regeneration. Cell Transplant. 2004, 13:15-25.
15. Bilican B., Fiore-Heriche C., Compston A., et al. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS One 2008, 3:e2863.
16. Cao X., Chen D. The BMP signaling and in vivo bone formation. Gene 2005, 357:1-8.
17. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
18. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16:251-263.
19. Wan M., Cao X. BMP signaling in skeletal development. Biochem. Biophys. Res. Commun. 2005, 328:651-657.
20. Mundy G., Garrett R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
21. Garrett I.R., Chen D., Gutierrez G., et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J. Clin. Invest. 2003, 111:1771-1782.
22. Zhao M., Ko S.Y., Liu J.H., et al. Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2. Mol. Cell. Biol. 2009, 29:1291-1305.
23. Zhao M., Qiao M., Harris S.E., et al. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol. Cell. Biol. 2006, 26:6197-6208.
24. Tang D., Hou W., Zhou Q., et al. Osthole stimulates osteoblast differentiation and bone formation by activation of β-Catenin-BMP signaling. J. Bone Miner. Res. 2010, 6:1234-1245.